The 21st century is truly shaping up to be biopharma’s golden age. With innovation in so many fields, from scientific progress in academia through the discovery of novel therapies to the use of big data, real-world evidence, artificial intelligence and other evolving tools, R&D has never been so diverse nor so exciting. And this year’s Scrip Awards rewarded excellence in all aspects of the industry’s activities over the past year.
The Scrip Awards categories range from those that applaud the broader achievements of companies, to those for innovation in deal...





![Spotlight On RDCs, AOCs As Leading Novel Bioconjugates[Updated]](https://web.insights.norstella-labs.com/resizer/v2/3M7ZAWZOBNK7NG4A4WDOIFG6DU.jpg?smart=true&auth=392a1fdb3cfacb29445720c412410e598dbcc5f90f14857652cd498bd0faa0fb&width=400&height=225)
